00-0000000 true --12-31 0001613780 false 0001613780 2026-06-03 2026-06-03 0001613780 us-gaap:CommonStockMember 2026-06-03 2026-06-03 0001613780 dei:AdrMember 2026-06-03 2026-06-03
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

June 3, 2026

Date of Report (Date of earliest event reported)

 

 

DBV Technologies S.A.

(Exact name of registrant as specified in its charter)

 

 

 

France   001-36697   Not applicable
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

107 avenue de la République
92320 Châtillon France
  Not Applicable
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: +33 1 55 42 78 78

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Ordinary shares, nominal value €0.10 per share   n/a   The Nasdaq Stock Market LLC*
American Depositary Shares, each representing five ordinary shares, nominal value €0.10 per share   DBVT   The Nasdaq Stock Market LLC

 

*

Not for trading, but only in connection with the listing of the American Depositary Shares on The Nasdaq Stock Market LLC.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On June 3, 2026, in connection with the shareholder vote at the Annual General Meeting (as defined below), the shareholders of the Company amended the Company’s bylaws (statuts), effective immediately.

Articles 18 and 21 of the bylaws have been modified to comply with the provisions of French law decree nº2026-94 of February 13, 2026, regarding the Ordinary Share Record Date. Article 15 of the bylaws has been amended to set the age limit for the Chief Executive Officer at 70 years, providing that no person aged 70 or over may be appointed as Chief Executive Officer and that, when such age limit is reached during the term of office, the duties of the Chief Executive Officer shall automatically cease at the end of the Ordinary General Meeting of Shareholders convened to approve the financial statements for the financial year in which the Chief Executive Officer reaches the age limit.

The foregoing description is qualified in its entirety by reference to the full text of the bylaws, the English translation of which is attached hereto as Exhibit 3.1 and is incorporated herein by reference.

 

Item 5.07

Submission of Matters to a Vote of Security Holders.

On June 3, 2026, the Company held its Annual Combined Meeting of Shareholders (“Annual General Meeting”). At the Annual General Meeting, the Company’s shareholders voted on the thirty-nine proposals set forth below. The voting results with respect to each matter voted upon at the Annual General Meeting are set forth below. A more detailed description of each proposal is set forth in the Company’s Proxy Statement filed with the Securities and Exchange Commission on May 11, 2026.

Within the authority of the Ordinary Shareholders’ Meeting:

 

1.

The resolution approving the annual financial statements for the year ended December 31, 2025 was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

190,121,468   499,104   109,298

 

2.

The resolution approving the consolidated financial statements for the year ended December 31, 2025 was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

190,120,075   499,182   110,613

 

3.

The resolution allocating income for the year ended December 31, 2025 was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

190,083,191   517,230   129,449

 

4.

The resolution allocating the accumulated deficit to the “Additional paid-in capital” was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

189,903,938   686,203   139,729

 

5.

The resolution regarding the statutory auditors’ special report on regulated agreements was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

189,953,469   643,692   132,709


6.

The resolution regarding the renewal of the term of office of KPMG, as statutory auditor, was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

190,030,444   559,162   140,264

 

7.

The resolution ratifying the provisional appointment of Ms. Philina Lee, as director, was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

189,933,070   576,503   220,297

 

8.

The resolution renewing Mr. Michael J. Goller, as director, was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

184,088,474   6,434,694   206,702

 

9.

The resolution renewing Mr. Daniel Tassé, as director, was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

189,963,580   572,553   193,737

 

10.

The resolution renewing Ms. Maïlys Ferrère, as director, was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

184,843,380   5,679,732   206,758

 

11.

The resolution approving the information set out in section I of Article L.22-10-9 of the French Commercial Code on the compensation of corporate officers for the year ended December 31, 2025 was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

186,194,144   4,392,687   143,039

 

12.

The resolution approving the fixed, variable and non-recurring components of overall compensation and benefits of all types paid or assigned during the year ended December 31, 2025, to Mr. Michel de Rosen, Chairman of the Board of Directors, was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

189,809,255   745,457   175,158

 

13.

The resolution approving the fixed, variable and non-recurring components of overall compensation and benefits of all types paid or assigned during the year ended December 31, 2025, to Mr. Daniel Tassé, Chief Executive Officer, was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,542,147   27,019,628   168,095

 

14.

The resolution regarding the advisory opinion on the compensation of named executive officers other than the Chief Executive Officer was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,642,700   26,944,966   142,204


15.

The resolution regarding the increase of the total remuneration (annual budget) allocated to Directors was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

189,507,135   1,133,707   89,028

 

16.

The resolution approving the compensation policy for the Chairman of the Board of Directors for the year ending December 31, 2026, was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,853,126   26,746,610   130,134

 

17.

The resolution approving the compensation policy for the Directors for the year ending December 31, 2026, was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,712,437   26,888,763   128,670

 

18.

The resolution approving the compensation policy for the Chief Executive Officer and Deputy Chief Executive Officer for the year ending December 31, 2026 was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,659,650   26,938,208   132,012

 

19.

The resolution authorizing the Board of Directors to buy back company shares on the Company’s behalf pursuant to Article L.22-10-62 of the French Commercial Code was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

190,044,199   578,978   106,693

Within the authority of the Extraordinary Shareholders’ Meeting:

 

20.

The resolution delegating to the Board of Directors to reduce the share capital by cancellation of shares pursuant to Article L.22-10-62 of the French Commercial Code was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

178,709,924   11,905,250   114,696

 

21.

The resolution delegating authority to the Board of Directors to issue ordinary shares and/or equity securities giving access to other equity securities or to the allocation of debt securities and/or securities giving access to ordinary shares with preferential subscription rights was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,957,492   26,604,297   168,081

 

22.

The resolution delegating authority to the Board of Directors to issue ordinary shares and/or equity securities giving access to other equity securities or to the allocation of debt securities, and/or securities giving access to equity securities to be issued, without preferential subscription rights by means of a public offer excluding the offers set out in paragraph 1 of Article L.411-2 of the French Monetary and Financial Code, and/or as consideration for securities in the context of a public exchange offer was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,540,160   27,013,589   176,121


23.

The resolution delegating authority to the Board of Directors to issue ordinary shares and/or equity securities giving access to other equity securities or to the allocation of debt securities, and/or securities giving access to equity securities to be issued, without preferential subscription rights by means of a public offer referred to in paragraph 1 of Article L.411-2 of the French Monetary and Financial Code was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,511,162   27,041,733   176,975

 

24.

The resolution delegating powers to the Board of Directors to issue ordinary shares and/or equity securities giving access to other equity securities or to the allocation of debt securities and/or securities giving access to ordinary shares, without preferential subscription rights in favor of one or more persons specifically designated by the Board of Directors was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,479,331   27,045,946   204,593

 

25.

The resolution delegating authority to the Board of Directors to issue ordinary shares, giving, as the case may be, access to ordinary shares or the allocation of debt securities (of the Company or a group company) and/or securities giving access to ordinary shares (of the Company or a group company), without preferential subscription rights in favor of a category of persons satisfying determined characteristics was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,482,259   27,043,570   204,041

 

26.

The resolution delegating authority to the Board of Directors to decide on the issue of ordinary shares to be issued immediately or in the future by the Company, without preferential subscription rights in favor of a category of persons satisfying determined characteristics within the framework of an equity financing agreement on the United States stock market known as “At-The-Market” or “ATM Program” was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,591,321   26,997,592   140,957

 

27.

The resolution delegating authority to the Board of Directors to increase the number of securities to be issued in the event of a capital increase with or without preferential subscription rights, in the event of excess demand was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,648,862   26,941,679   139,329

 

28.

The resolution delegating to the Board of Directors to increase the share capital by issuance of ordinary shares and/or securities giving access to the share capital within the limits set by the applicable legal and regulatory provisions on the date of the capital increase in consideration for contributions in kind of securities or securities giving access to the share capital was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,704,689   26,896,892   128,289

 

29.

The resolution delegating authority to the Board of Directors to decide on any merger-absorption, spin-off or partial contribution of assets was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

151,575,334   38,969,127   185,409


30.

The resolution delegating authority to the Board of Directors to issue ordinary shares giving, as the case may be, access to ordinary shares or to the allocation of debt securities (of the Company or of a group company), and/or securities giving access to ordinary shares (of the Company or of a group company), in the context of a merger, spin-off or partial contribution of assets decided by the Board of Directors pursuant to the delegation referred to in the twenty-ninth resolution was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

173,977,797   16,563,371   188,702

 

31.

The resolution regarding the overall limit on the maximum authorized amounts set under the twenty-second, twenty-third, twenty-fourth, twenty-fifth, twenty-sixth, twenty-eighth and thirtieth resolutions was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

189,934,713   641,446   153,711

 

32.

The resolution delegating authority to the Board of Directors to increase the capital by means of the incorporation of reserves, profits and/or premiums was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

188,531,612   2,064,866   133,392

 

33.

The resolution delegating authority to the Board of Directors to increase the capital by the issue of ordinary shares and/or securities giving access to the share capital, without preferential subscription rights in favor of the members of a company savings plan pursuant to Articles L.3332-18 and seq. of the French Labor Code was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

181,766,144   8,830,270   133,456

 

34.

The resolution delegating authority to the Board of Directors to issue warrants (BSA), subscription and/or acquisition of new and/or existing warrants (BSAANE) and/or subscription and/or acquisition of new and/or existing redeemable warrants (BSAAR) without preferential subscription rights in favor of a category of persons was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,608,590   26,993,131   128,149

 

35.

The resolution authorizing the Board of Directors to allocate for free existing and/or to be issued shares to employees and/or certain corporate officers of the Company or related companies or economic interest groups was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

163,776,980   26,880,444   72,446

 

36.

The resolution authorizing the Board of Directors to grant stock options to employees and/or certain officers of the Company or related companies or economic interest groups was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

171,812,106   18,843,706   74,058


37.

The resolution regarding the overall limit on the maximum authorized amounts set under the thirty-fifth and thirty-sixth resolutions was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

189,978,750   621,387   129,733

 

38.

The resolution ratifying the amendment to Article 18 and Article 21 of the Company’s bylaws was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

181,924,828   8,643,388   161,654

 

39.

The resolution regarding the amendment to Article 15 of the Company’s bylaws to set the age limit for the Chief Executive Officer at 70 years was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

175,397,495   15,184,713   147,662

Within the authority of the Ordinary Shareholders’ Meeting:

 

40.

The resolution regarding powers to complete formalities was approved, based on the following votes:

 

Voted For

 

Voted Against

 

Vote Withheld

190,077,851   525,038   126,981

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
No.
  

Description

3.1    Amended and Restated By-laws (statuts) of DBV Technologies S.A. (English Translation)
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 3, 2026   DBV TECHNOLOGIES S.A.
    By:  

/s/ Virginie Boucinha

    Name:   Virginie Boucinha
    Title:   Chief Financial Officer